Healthtech and edtech are two of the fastest growing sectors, with the healthtech market size to reach $3.1 billion by 2033, while the global education technology market size is projected to reach $348.41 billion by 2030.
Each week will do a roundup of the top news, fundings, and IPOs from these two sectors.
Top News
- Connected health data network b.well Connected Health announced partnerships with weight-loss company Noom, cardiometabolic-focused healthcare technology company Welldoc and health insurance company Humana, as a part of each company’s commitment to the CMS Health Technology Ecosystem. Humana will allow individuals to connect and access their health data across providers, health plans, pharmacies and digital health applications; Welldoc, which offers an AI-enabled app for cardiometabolic health, will be able to access patient-authorized health data and users will be able to access their health information through b.well’s national health data network; and Noom and b.well will jointly launch Noom Health Record Connect, which will enable Medicare beneficiaries to connect their medical records to the Noom app
- Pikmykid, a company that allows educators and institution leaders to manage dismissals and reunification, provide digital hall passes and send out emergency alerts, was acquired by Atlanta-based safety solutions company Centegix
AI News
- HCA Healthcare’s Good Samaritan Hospital partnered with RapidAI, which empowers clinicians to make accurate diagnostic and treatment decisions for stroke and aneurysm patients, to implement Lumina 3D, an AI-driven imaging solution that creates detailed three-dimensional views of blood vessels in the brain and neck from CT scans
- Meta introduced its first AI glasses built for prescriptions that are available in two styles: Blayzer, a rectangular design available in Standard and Large sizes, and Scriber, a more rounded frame style
- Harford HealthCare and K Health, a data-driven digital primary care system that uses AI to deliver personalized primary care services, partnered to launch PatientGPT, a new AI system with the ability to securely access the user’s medical record and link to a virtual visit upon request
- Fenty Beauty, a cosmetics brand that offers a wide range of hard-to-match skin tones for all skin types, partnered With WhatsApp to launch a conversational AI-powered beauty advisor
- OpenProtein.AI, a provider of AI-powered protein engineering software, expanded its partnership with Boehringer Ingelheim to co-develop specialized antibody discovery and optimization workflows
- Headway, a company building a new mental healthcare system that everyone can access, acquired the team behind Tezi, an AI-native company that developed systems designed to combine human judgment with AI agents within complex workflows
- Gyde, an AI-native brokerage platform, acquired Avid Health, a Medicare agency empowering a new generation of elite brokers to serve as comprehensive, trusted guides across insurance, wealth, and health
- AECOM, a global infrastructure provider, partnered with Southern Methodist University, establishing a framework to advance artificial intelligence driven research, workforce readiness, and long-term talent development in infrastructure engineering
Really big financings:
Healthtech:
- Sidewinder Therapeutics, a biopharmaceutical company pioneering the development of next-generation bispecific antibody-drug conjugates for the treatment of cancer, raised a $137 million Series B round co-led by Frazier Life Sciences and Novartis Venture Fund, with participation from the sole Series A investor OrbiMed as well as new investors including Life Sciences at Goldman Sachs Alternatives, DCVC Bio, Samsara BioCapital, Longwood Fund, Astellas Venture Management and Alexandria Venture Investments
- Oricell, a clinical-stage biotechnology company pioneering cancer immunotherapies, raised a pre-IPO financing round in excess of $110 million co-led by Vivo Capital, Beijing Medical and Health Care Industry Investment Fund, Qiming Venture Partners, and a leading global healthcare fund. The syndicate included an international sovereign wealth fund, E-Town Capital, Luxin Venture Capital, NGS Super, Elikon Investment, and Talon Capital
- Stipple Bio, a private biotechnology company harnessing epitope-level precision to create targeted cancer therapies, raised $100 million in a round co-led by RA Capital, a16z Bio+Health and Nextech Invest, and includes participation from existing investors Emerson Collective Investments, GV, LoLa Capital Partners and GordonMD Global Investments, among others
- Chapter, a Medicare navigation platform, raised $100 million in a Series E funding round led by Generation Investment Management, with participation from new investors Fifth Down Capital, 8VC, as well as the company’s existing investors: Stripes, XYZ Venture Capital, Addition, Narya Capital, Susa Ventures, and Maverick Ventures
Big financings:
Healthtech:
- SimpliFed, a virtual maternal healthcare platform, raised $10.8 million in an oversubscribed Series A round led by Morningside and Hesperia Capital with participation from Foreground Capital and additional investors
- Endovascular Engineering, a commercial-stage medical technology company focused on advancing the treatment of venous thromboembolism, raised an $80 million Series C financing co-led by Gilde Healthcare and Norwest, with participation from existing investors including Santé Ventures, 415 Capital, S3 Ventures, Panakès Partners, M&L Healthcare Investments, as well as the two existing undisclosed strategic investors and a new global strategic investor
- Click Therapeutics, which develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs, raised $50 million from Boehringer Ingelheim
- Route 92 Medical, a medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, raised a $50 million growth financing from new investor Sectoral Asset Management joined lead investor Novo Holdings and returning investors U.S. Venture Partners, Norwest Venture Partners, InnovaHealth Partners, and The Vertical Group in the financing round
- ReAlta Life Sciences, a clinical-stage biopharmaceutical company focused on safely targeting neutrophils and central components of the complement system to potentially revolutionize the treatment of inflammatory disorders, raised $40 million from undisclosed investors
- Yuzu Health, a third-party administrator providing claims processing, billing, and plan management for employer-sponsored insurance plans, raised $35 million in a round led by General Catalyst and Chemistry, with participation from Anthropic’s and Menlo Ventures’ Anthology Fund, Bain Future Back Ventures, Timeless Ventures, Lachy Groom, and Neo
- HeyDonto, which offers AI solutions for dental EHR integration, raised a $20 million seed funding round led by eight leading private investors who are practicing dentists and dental industry veterans
- Beacon Biosignals raised an additional $11 million for its Series B financing from new investors JSL Health, Palo Santo VC, Kicker Ventures, and Samsung Next
- Insight Health, a clinical agent platform for healthcare, raised an $11 million Series A funding round led by Standard Capital, with participation from Pear VC, Kindred Ventures, Eudemian, ElevenLabs, and 43
Not so big financings:
Healthtech:
- neuroClues, developer of a medical device that records and analyzes eye movements, raised a €10 million Series A round led by Teampact Ventures, White Fund and the EIC Fund, with participation from existing investors InvestBW, Leansquare, and Wallonie Entreprendre, and the support of Olivier Legrain
- TeiaCare, developer of care-monitoring solutions for residential healthcare facilities such as nursing homes, rehabilitation centres, and dementia care units, raised €7 million in a funding round led by P101 SGR, with participation from existing shareholders and new healthcare-focused investors, including Spanish family offices Namarel and Inderhabs
- Incyclix Bio, a cell cycle control company developing a CDK2 inhibitor for the treatment of advanced and resistant cancer, raised $5 million in additional funds for its Series B financing from new investor Hatteras Venture Partners
- Flora Fertility, a provider of individually owned fertility insurance that isn’t tied to an employer, raised $5 million in seed funding in a round led by ManchesterStory with participation from Slauson & Co., BDC, and existing investors
- DeepCyte, a techbio company building AI toxicology tools for drug development, raised $1.5 million in seed funding from undisclosed investors
Policy and government
- Governor Jeff Landry signed an executive order to create a new office that focuses on improving rural healthcare in Louisiana, establishing the Office of Rural Health Transformation and Sustainability within the Louisiana Department of Health. The new office will help put the initiatives of Louisiana’s Rural Health Transformation Program into place. Officials said the goal of everything is to work toward better maternal and infant health outcomes, a lower burden for chronic disease, more access to behavioral health services, and earlier detection and treatment for serious conditions like cancer
- The U.S. Departments of Education and Labor issued the Fiscal Year 2026 competitions for the Teacher and School Leader Incentive Program and the Innovative Approaches to Literacy Program. These competitions represent the next step in the Trump Administration’s efforts to align workforce and education programs, expand education freedom, and bolster educator effectiveness.
Random news
- In a recent series of TikTok videos, adventurer Liam Porter is documenting his pond water consumption. Filming like a budget Bear Grylls, Porter says into the camera, “Day one, drinking pond water until I get giardia,” he says. Next, he bends down and scoops up a big blue cup full of water. Then he proceeds to drink, all while keeping one wild eye on his camera. According to one user, a self-identified health professional admits, “as a healthcare worker, I’m urged to beg you to stop. However, as a microbiologist I’m fascinated”
